16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients
Clinical trial NCT02008916 · COMPLETED
Trial details
- NCT number
- NCT02008916
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-14
- Primary completion
- 2015-02-23
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.